Paper36909174
Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis.
Liu X and 5 others. Front Pharmacol, 2023. Cited by 51 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Papers, record 36909174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36909174
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32671444 | Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression. | Arch Toxicol | 2020 | https://conductscience.org/library/papers/32671444 | PubMed |
| 2 | 33462123 | Modes of Regulated Cell Death in Cancer. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33462123 | PubMed |
| 3 | 36048734 | Construction of Wogonin Nanoparticle-Containing Strontium-Doped Nanoporous Structure on Titanium Surface to Promote Osteoporosis Fracture Repair. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/36048734 | PubMed |
| 4 | 24840647 | Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. | Cancer Res | 2014 | https://conductscience.org/library/papers/24840647 | PubMed |
| 5 | 33574569 | Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications. | Acta Pharmacol Sin | 2021 | https://conductscience.org/library/papers/33574569 | PubMed |
| 6 | 32629871 | NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32629871 | PubMed |
| 7 | 14757129 | Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. | Eur J Pharmacol | 2004 | https://conductscience.org/library/papers/14757129 | PubMed |
| 8 | 33000412 | Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. | Protein Cell | 2021 | https://conductscience.org/library/papers/33000412 | PubMed |
| 9 | 6086389 | Lipid peroxidation initiated by superoxide-dependent hydroxyl radicals using complexed iron and hydrogen peroxide. | FEBS Lett | 1984 | https://conductscience.org/library/papers/6086389 | PubMed |
| 10 | 30692038 | NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. | Redox Biol | 2019 | https://conductscience.org/library/papers/30692038 | PubMed |
| 11 | 22632970 | Ferroptosis: an iron-dependent form of nonapoptotic cell death. | Cell | 2012 | https://conductscience.org/library/papers/22632970 | PubMed |
| 12 | 32122374 | Metabolism of pancreatic cancer: paving the way to better anticancer strategies. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32122374 | PubMed |
| 13 | 23955116 | Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells. | Cell Biol Toxicol | 2013 | https://conductscience.org/library/papers/23955116 | PubMed |
| 14 | 33302392 | Iron Therapeutics in Women's Health: Past, Present, and Future. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33302392 | PubMed |
| 15 | 35075250 | The multifaceted role of ferroptosis in liver disease. | Cell Death Differ | 2022 | https://conductscience.org/library/papers/35075250 | PubMed |
| 16 | 33145265 | Wogonin reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12-CXCR4/7 axis in bone marrow microenvironment. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/33145265 | PubMed |
| 17 | 30925886 | Ferroptosis, a new form of cell death: opportunities and challenges in cancer. | J Hematol Oncol | 2019 | https://conductscience.org/library/papers/30925886 | PubMed |
| 18 | 34630106 | Establishment of a Lung Cancer Discriminative Model Based on an Optimized Support Vector Machine Algorithm and Study of Key Targets of Wogonin in Lung Cancer. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34630106 | PubMed |
| 19 | 33711551 | Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: Insights from experimental studies, mechanistic actions to clinical applications. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/33711551 | PubMed |
| 20 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957908 | Mechanisms of ferroptosis in Echinococcus granulosus cyst fluid-induced hepatic injury and the protective role of Nrf2 activation. | Parasitol Res | 2026 | https://conductscience.org/library/papers/42957908 | PubMed |
| 42700331 | Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42700331 | PubMed |
| 42510622 | Wogonin Suppresses Non-Small Cell Lung Cancer Growth in Association with Oxidative Stress, c-Myc/GPX4 Downregulation and Ferroptosis-Related Responses. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42510622 | PubMed |
| 42357386 | Research Progress on Chinese Herbal Medicine Components Targeting Ferroptosis for Cancer Therapy. | Molecules | 2026 | https://conductscience.org/library/papers/42357386 | PubMed |
| 42318966 | Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer. | Oncol Rep | 2026 | https://conductscience.org/library/papers/42318966 | PubMed |
| 41748567 | Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41748567 | PubMed |
| 41547783 | Ferroptosis in cancer toward molecular insights and clinical translation in pancreatic cancer. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41547783 | PubMed |
| 41164269 | Anticancer Potential of Wogonin: A Comprehensive Treatise. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/41164269 | PubMed |
| 41037250 | Wogonin improves high glucose-induced ARPE-19 cell damage by inhibiting ferroptosis via suppressing the cGAS-STING pathway. | In Vitro Cell Dev Biol Anim | 2025 | https://conductscience.org/library/papers/41037250 | PubMed |
| 40994946 | Natural products targeting ferroptosis in cancer: molecular mechanisms and applications. | Front Oncol | 2025 | https://conductscience.org/library/papers/40994946 | PubMed |
| 40960518 | The ferroptosis-ncRNA-exosome triad: key orchestrators in cancer immunopathogenesis. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/40960518 | PubMed |
| 40673298 | [Shuangshu Decoction inhibits growth of gastric cancer cell xenografts by promoting cell ferroptosis via the P53/SLC7A11/GPX4 axis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | https://conductscience.org/library/papers/40673298 | PubMed |
| 40659085 | Flavonoid-mediated modulation of ferroptosis: therapeutic potential in gastrointestinal cancers. | J Adv Res | 2026 | https://conductscience.org/library/papers/40659085 | PubMed |
| 40444042 | Wogonin inhibits the proliferation of prolactinoma through the PI3K/AKT signaling pathway. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40444042 | PubMed |
| 40439491 | Monotropein Induced Ferroptosis to Alleviate the Progression of Hepatocellular Carcinoma via Regulating Nrf2/HO-1/GPX4 Axis. | Kaohsiung J Med Sci | 2025 | https://conductscience.org/library/papers/40439491 | PubMed |
| 40205009 | Wogonin attenuates septic cardiomyopathy by suppressing ALOX15-mediated ferroptosis. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40205009 | PubMed |
| 40185230 | Tissue inhibitor of metalloproteinase 1 promotes ferroptosis and suppresses prostate cancer metastasis. | J Biol Chem | 2025 | https://conductscience.org/library/papers/40185230 | PubMed |
| 39960579 | Ferroptosis in senescence and age-related diseases: pathogenic mechanisms and potential intervention targets. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39960579 | PubMed |
| 39886791 | Recent Advancements in Drug Targeting for Ferroptosis as an Antitumor Therapy: Development of Novel therapeutics. | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/39886791 | PubMed |
| 39754171 | Immune-related gene SOX10 affects ferroptosis in pancreatic cancer and facilitates tumor progression by targeting CMTM7-mediated Wnt/β-catenin signaling pathway. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/39754171 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36909174
GET https://conductscience.org/api/papers/v1/36909174/references?page=2